Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9%

AuthorsPhilip A. Clayton, McArthur, C, McConnochie, R, Mount, P, Reidlinge, D, Robison, L, Varghese, J, Vergara, L, Weinberg, L, BEST-Fluids Investigators; Australasian Kidney Trials Network, Collins, M, Dansie, K, Fahim M, Howard, K, Johnson, D, Pascoe, E

Periodical/sTrials